10-Q quarterly report · filed Nov 9, 2026

Inogen Inc (INGN) Q3 2026 10-Q Quarterly Report

Short answer

Inogen Inc (INGN) filed its Q3 2026 10-Q quarterly report on Nov 9, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $53M (down 42.7% year over year) with net income of −$16M.

Q3 2026 key financials · XBRL

Revenue
$53M
−42.7% YoY · −44.3% QoQ
Net income
−$16M
−205.2% YoY · −319.6% QoQ
Operating margin
-26.5%
Gross margin
44.7%
EPS (diluted)
−$0.60
−215.8% YoY · −300.0% QoQ

Source: XBRL data from the Inogen Inc (INGN) Q3 2026 10-Q on SEC EDGAR. USD.

Inogen Inc Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $77.2M, down 2.4% YoY from $79.1M, with U.S. sales up 3.8% and international sales down 9.0%
  • Gross margin 44.1% vs 45.7% YoY; continuing-operations loss $14.8M vs $3.6M, including $10.6M goodwill impairment
  • Best market: U.S. sales $42.2M, up 3.8%; weakest: international sales $34.9M, down 9.0%
  • Cash $81.8M plus marketable securities $15.0M; operating cash use $13.6M through nine months, share repurchases $11.2M
  • Rental-business sale up to $24.8M; cost program targeting $20M annualized savings, with supply-chain, inflation, geopolitical, and freight headwinds

Risk Factors

  • New divestiture risk triggered by November 2 Rental Business sale: Rotech consideration up to $24.8 million payable in six installments
  • Regulatory and compliance risk: patient transfers require HIPAA, state privacy, and payor compliance
  • Operational risk: Rental Business revenue of $35.6 million eliminated, increasing dependence on product sales
  • Cost-reduction risk triggered by November 5 program: approximately $20 million annualized savings may not materialize
  • Financial risk: retained Rental Business liabilities include potential Medicare, Medicaid, and payor recoupment demands

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Inogen Inc quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.